Bond Screener
Astrazeneca Finance
LEI 549300C3HATU4Q460S18
Organization name
Astrazeneca Finance LLC
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
9,250 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Astrazeneca Finance LLC provides financial services. The Company serves customers in the United States.
|
General information
-
Organization nameAstrazeneca Finance LLC
-
Organization statusOperating organization
-
AddressC/O THE CORPORATION TRUST COMPANY, WILMINGTON, USA, 19801
News
-
New issues: Astrazeneca Finance released international bonds (US04636NAK90, US04636NAL73, US04636NAM56, US04636NAN30) in the amount of USD 1250, USD 1250, USD 1000, USD 1500 mln maturing in 2027, 2029, 2031, 2034 respectively.23/02/2024
-
New issues: Issuer Astrazeneca Finance released international bonds (US04636NAF06, US04636NAG88, US04636NAH61) in the amount of USD 1100, USD 650, USD 500 mln maturing in 2028, 2030, 2033 respectively.02/03/2023
-
New bond issue: Astrazeneca Finance issued international bonds (US04636NAE31) with a 1.75% coupon for USD 1,250.0m maturing in 202826/05/2021
-
New bond issue: Astrazeneca Finance issued international bonds (US04636NAC74) with a 0.7% coupon for USD 1,600.0m maturing in 202426/05/2021
-
New bond issue: Astrazeneca Finance issued international bonds (US04636NAA19) with a 1.2% coupon for USD 1,250.0m maturing in 202626/05/2021
Affiliates
Stocks
Bond classification
- Organization does not disclose IFRS/US GAAP financial statements
